Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 November 2024 | Story Leonie Bolleurs | Photo Tania Allen
Business School Partnership 2024
Prof Per Assmo from University West, Sweden and Prof Anthea Rhoda from the UFS signed a Memorandum of Understanding that will develop academic cooperation across fields such as research, student and academic exchanges, and collaborative projects.

The University of the Free State (UFS) has signed a Memorandum of Understanding (MOU) with University West, Sweden. Held at the UFS Business School on the Bloemfontein Campus, the event saw the signing of the agreement by Prof Anthea Rhoda, acting UFS Vice-Chancellor and Principal, and Prof Per Assmo, Deputy Vice-Chancellor for Internationalisation at University West. The partnership aims to develop academic cooperation across fields such as research, student and academic exchanges, and collaborative projects.

This MOU opens the door to a wide range of collaborative initiatives, including academic and researcher exchanges for the purposes of teaching, conducting lectures, conducting research, and exchanging expertise. Additionally, the MOU includes student exchange programmes, joint research projects, and the shared hosting of seminars and conferences.

Prof Rhoda shared her enthusiasm to incorporate work-integrated learning (WIL) more widely at the UFS. “We are looking at work-integrated learning as an extension of engaged scholarship. It is something that we're looking forward to expanding,” she said.

Building a connected community

Prof Assmo explained that their institution, though small, has a unique approach that focuses on both production technology and work-integrated learning – a teaching model that goes beyond internships to provide students with practical, hands-on experience. "For us, WIL is a research field and academic discipline in its own right," he said.

University West is also the only university in the world to offer a PhD specifically in WIL, a programme it spent 20 years developing.

“We want to collaborate with South Africa as a strategic partner,” he said. The University West is already actively working with several South African universities, including the UFS, the Central University of Technology, the University of the Western Cape, and Tshwane University of Technology. “This would be the core for us, where we collaborate and find different forms within research and education, not restricted to any faculty or field as such.”

His vision also includes forming a larger ‘Nordic hub’ of connections across Sweden, Norway, and the European Union, along with a ‘regional hub’ in Bloemfontein. This way, universities can share ideas and resources to build a stronger, more connected community for the future.

A need for work-integrated learning

A working example of this partnership between University West and the UFS is the collaborative focus on integrated learning between Prof Liezel Massyn, Associate Professor in the UFS Business School, and Prof Kristina Areskoug Josefsson, Professor in Work-integrated Learning and Health Science from University West. They have a mutual commitment to improve educational practices through international partnerships and to advance integrated learning strategies. Together, they have already co-authored a research article and presented their findings at five conferences this year.

Prof Massyn said she realised that there is a need for work-integrated learning, specifically in the UFS Business School. “Initially, I thought our students were working, so they didn't need the work-integrated learning component. I then realised it could actually add a lot more value.”

Prof Nicolene Barkhuizen, Director of the UFS Business School, highlighted how this venture aligns with the university’s Vision 130, which aims to expand the UFS’ global footprint. “This partnership is an optimisation of the collaboration to contribute to Vision 130, expanding our reach globally while bringing practical value locally. We are looking forward to a very fruitful collaboration,” she said.

Speaking on behalf of the Faculty of Economic and Management Sciences, acting Dean Prof Frans Prinsloo discussed the potential for future projects. “Now that we have this collaboration agreement, there are many opportunities we can explore further,” he stated.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept